Last Updated: May 14, 2026

Claims for Patent: 10,603,445

✉ Email this page to a colleague

Summary for Patent: 10,603,445

Title:	Needle actuator assembly for drug delivery system
Abstract:	A needle actuator assembly for a drug delivery system includes a needle actuator body having a guide surface, a needle shuttle having a cam surface, with the needle shuttle moveable along a vertical axis between a first position and a second position. The needle shuttle is configured to move between the first and second position through engagement between the guide surface of the needle actuator body and the cam surface of the needle shuttle. The assembly further including a needle received by the needle shuttle.
Inventor(s):	Michael Vincent Quinn, Mohammed Yassir Mahdi, Oliver Charles Gazeley, James Alexander Senior, Malcolm Stanley Boyd
Assignee:	Becton Dickinson and Co
Application Number:	US15/616,212

Details for Patent 10,603,445

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	XOLAIR	omalizumab	For Injection	103976	June 20, 2003	10,603,445	2037-06-07
Genentech, Inc.	XOLAIR	omalizumab	Injection	103976	September 28, 2018	10,603,445	2037-06-07
Genentech, Inc.	XOLAIR	omalizumab	Injection	103976	August 17, 2023	10,603,445	2037-06-07
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,603,445

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2017214415	⤷ Start Trial
United States of America	2025281699	⤷ Start Trial
United States of America	2023248920	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.